Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by Jennifer2020on Aug 30, 2022 4:35am
83 Views
Post# 34928800

RE:VPT Financials and Sales Update on SEDAR Today

RE:VPT Financials and Sales Update on SEDAR TodayMost companys on the Venture and other junior exchanges have accumulated deficits.  This quarter was expensive because of staff expansion to handle GEHC collaboration in selling Vivid 4D as GEHC prepares to spinoff parent GE in "early 2023"
  You posted the share float incorrectly as well.  It's 155,6XX,XXX plus 705k with options just excised by mgmt.  That was reported at the very end of MD&A as Subsequent Events where the majority of options were at .30 and .33.  
   Stockwatch has pulled down Aug 26 news release to update share count.  When an article is first released there it has no share count in top right blue box.  Sedar release triggerred them to update aug 26 release which will be back up at any time now giving us an easy accurate float total.
<< Previous
Bullboard Posts
Next >>